Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute-onset endophthalmitis following pars plana vitrectomy for symptomatic vitreous opacities: a case series.

International journal of retina and vitreous·2026
Same author

Endocrine Mucin-Producing Sweat Gland Carcinoma of Eyelid.

Ophthalmology·2026
Same author

Increased Risk for Ocular Surface Neoplasia in Recipients of Solid Organ Transplant.

American journal of ophthalmology·2026
Same author

Conjunctival Intraepithelial Neoplasia With IgG and Complement Deposition: Spurious Association or Biologically Explainable?

Cureus·2026
Same author

Keratocyte Depletion by Genetic Manipulation Re-creates Corneal Ectasia in a Mouse Model.

The American journal of pathology·2026
Same author

Foster Kennedy Syndrome, Euthanasia, and the Purpose of Eponyms.

Neuro-ophthalmology (Aeolus Press)·2025

Related Experiment Video

Updated: Jul 7, 2026

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

Iris melanoma.

Evita Henderson1, Curtis E Margo

  • 1Department of Pathology, Veterans Administration Hospital, Tampa, USA.

Archives of Pathology & Laboratory Medicine
|February 7, 2008
PubMed
Summary

Iris melanoma, though rare, has a better prognosis than posterior uveal melanoma. This may be due to earlier diagnosis and smaller tumor size, with specific growth patterns potentially indicating recurrence risk.

Area of Science:

  • Ophthalmology
  • Oncology
  • Pathology

Background:

  • Uveal melanoma is a rare eye cancer originating in the uvea.
  • Iris melanoma is the least common subtype, affecting the iris.
  • Iris melanoma generally has a better prognosis than ciliary body or choroidal melanoma.

Purpose of the Study:

  • To investigate the factors contributing to the better prognosis of iris melanoma compared to posterior uveal melanomas.
  • To explore potential explanations for the observed prognostic differences.
  • To identify risk factors for local recurrence and metastasis in iris melanoma.

Main Methods:

  • Review of clinical data and histopathological findings of iris melanoma cases.
  • Comparison of tumor characteristics (size, cell type) between iris melanoma and posterior uveal melanoma.

More Related Videos

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Experiment Videos

Last Updated: Jul 7, 2026

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

  • Analysis of specific iris melanoma growth patterns, such as iris plaque and stromal invasion.
  • Main Results:

    • Iris melanomas are diagnosed at a smaller size compared to posterior uveal melanomas.
    • The majority of iris melanomas are of the spindle cell type.
    • Anterior iris surface melanocyte proliferation (iris plaque) and diffuse stromal invasion are associated with increased risk of recurrence and metastasis, respectively.

    Conclusions:

    • The smaller tumor size at diagnosis may contribute to the better prognosis of iris melanoma.
    • Specific histopathological features, including iris plaque and stromal invasion, are critical indicators for predicting iris melanoma outcomes.
    • Further research is needed to fully elucidate the mechanisms behind iris melanoma's prognosis and to refine risk stratification.